HT

Hitendra Tarachandra Chokshi

Active Director Additional Director DIN 11362928
DIN 11362928 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Hitendra Tarachandra Chokshi

Data last updated:

Hitendra Tarachandra Chokshi is an Additional Director at Pet Tech Med Mart Private Limited (since 2025).

DIN 11362928
Primary Designation Additional Director
First Appointment 24 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pet Tech Med Mart Private Limited U47734MH2024PTC427064
Additional Director24 Dec 2025Active

Board colleagues of Hitendra Tarachandra Chokshi

Directorship timeline

Open interactive timeline →
Pet Tech Med Mart Private Limited
Premium access

Shareholding and investment profile for Hitendra Tarachandra Chokshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hitendra Tarachandra Chokshi

Hitendra Tarachandra Chokshi currently holds 1 directorship: Pet Tech Med Mart Private Limited (Additional Director, since 24 Dec 2025).

Hitendra Tarachandra Chokshi was first appointed on 24 Dec 2025 as Additional Director at Pet Tech Med Mart Private Limited.

The current boards of Hitendra Tarachandra Chokshi's companies include Anil Valjibhai Patel (Pet Tech Med Mart Private Limited), Priyanka Dipen Patel (Pet Tech Med Mart Private Limited), Ronak Hitendra Chokshi (Pet Tech Med Mart Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available